<scp>cAMP</scp> ‐induced decrease in cell‐surface laminin receptor and cellular prion protein attenuates amyloid‐β uptake and amyloid‐β‐induced neuronal cell death-Reference-Cited by-同舟云学术

cAMP ‐induced decrease in cell‐surface laminin receptor and cellular prion protein attenuates amyloid‐β uptake and amyloid‐β‐induced neuronal cell death

Published:2022-08-15 Issue:22 Volume:596 Page:2914-2927
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Letters

Author:

Gopalakrishna Rayudu¹^ORCID,Lin Charlotte Y.¹,Oh Andrew¹,Le Calvin¹,Yang Seolyn¹,Hicks Alexandra¹,Kindy Mark S.²³,Mack William J.⁴,Bhat Narayan R.⁵

Affiliation:

1. Department of Integrative Anatomical Sciences, Keck School of Medicine University of Southern California Los Angeles CA USA

2. Department of Pharmaceutical Sciences, College of Pharmacy University of South Florida Tampa FL USA

3. James A. Haley VA Medical Center Tampa FL USA

4. Department of Neurological Surgery, Keck School of Medicine University of Southern California Los Angeles CA USA

5. Department of Neuroscience Medical University of South Carolina Charleston SC USA

Funder

Keck School of Medicine of USC

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.14467

Reference50 articles.

1. Alzheimer disease

2. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

3. Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease

4. “Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease

5. A Unifying Hypothesis for Alzheimer’s Disease: From Plaques to Neurodegeneration

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol and its metabolites elicit neuroprotection via high‐affinity binding to the laminin receptor at low nanomolar concentrations;FEBS Letters;2024-02-27

2. Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer’s disease prevention;Neural Regeneration Research;2023-04-10